A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling
Ylenia Ferrara(Institute of Biostructure and Bioimaging), Antonella Zannetti(Institute of Biostructure and Bioimaging)
Cited by 8
Related Papers
Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion
|Journal of Experimental & Clinical Cancer Research|2022|97
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
|Theranostics|2017|91
RETRACTED: A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity
|International Journal of Molecular Sciences|2020|66